Feasibility of radical gastrectomy for elderly patients with gastric cancer

Eur J Surg Oncol. 2016 Feb;42(2):303-11. doi: 10.1016/j.ejso.2015.11.013. Epub 2015 Dec 6.

Abstract

Background: The aim of this study was to evaluate the short-term safety and long-term benefits of radical gastrectomy for gastric cancer in elderly patients.

Methods: A total of 729 patients undergoing gastrectomy for adenocarcinoma between December 2008 and December 2011 were enrolled in this retrospective study. Patients were divided into three groups: young group (<65 years), young-old group (65-79 years) and old-old group (≥80 years).

Results: Lower albumin levels, higher ASA grades, comorbidities, tumors located in the upper third of the stomach and advanced TNM stages were more common in the young-old and old-old age groups. Overall complications increased significantly with advancing age (15.4%, 24.9%, 48.7%, respectively); respiratory complications largely contributed to the dramatic increase. Severe complications were similar between the young and young-old groups (3.9%, 3.7%), but were significantly increased in the old-old group (12.8%). In multivariate analysis, old-old age, multiple comorbidities and no epidural use were strong predictors for overall complications. Both overall survival and disease-specific survival (DSS) rates declined with advancing age. Multivariate analysis showed that old-old age and TNM stage ≥ II were major independent risk factors for the DSS rate. When adjusted for confounding factors, young-old age was not a risk factor. The median survival time for the old-old patients with stage III tumors was 12.9 months.

Conclusions: It is relatively safe and beneficial for young-old patients to undergo radical gastrectomy as the young patients. However, the decision to perform radical gastrectomy for old-old patients with TNM stage III tumors should be made carefully.

Keywords: Elderly patients; Gastrectomy; Gastric cancer; Postoperative complications; Survival.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenocarcinoma / pathology*
  • Adenocarcinoma / surgery*
  • Age Factors
  • Aged
  • Aged, 80 and over
  • Comorbidity
  • Female
  • Gastrectomy* / adverse effects
  • Health Status Indicators
  • Humans
  • Male
  • Middle Aged
  • Neoplasm Staging
  • Patient Selection
  • Respiratory Tract Diseases / etiology
  • Retrospective Studies
  • Risk Factors
  • Serum Albumin / analysis
  • Stomach Neoplasms / pathology*
  • Stomach Neoplasms / surgery*
  • Survival Rate
  • Time Factors

Substances

  • Serum Albumin